Company Nutriband Inc. Other OTC
Equities
NTRB
US67092M2089
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Pocono Pharmaceuticals
92.1
%
| 2 | 85.9 % | 2 | 92.1 % | +7.54% |
4P Therapeutics
7.9
%
| 0 | 14.1 % | 0 | 7.9 % | -43.89% |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | +0.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gareth Sheridan
FOU | Founder | 35 | 11-12-31 |
Serguei Melnik
FOU | Founder | 52 | 11-12-31 |
Gerald Goodman
DFI | Director of Finance/CFO | 76 | 18-07-30 |
Patrick Ryan
CTO | Chief Tech/Sci/R&D Officer | 38 | 18-01-31 |
Jeffrey Patrick
CTO | Chief Tech/Sci/R&D Officer | 55 | 18-05-14 |
Alan Smith
COO | Chief Operating Officer | 59 | 18-07-31 |
Larry Dillaha
CTO | Chief Tech/Sci/R&D Officer | 60 | 18-08-01 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Serguei Melnik
FOU | Founder | 52 | 11-12-31 |
Stefan Mancas
BRD | Director/Board Member | 48 | 18-06-30 |
Gareth Sheridan
FOU | Founder | 35 | 11-12-31 |
Mark Hamilton
BRD | Director/Board Member | 39 | 18-06-30 |
Radu Bujoreanu
BRD | Director/Board Member | 53 | 19-06-13 |
Director/Board Member | 36 | 22-01-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,046,100 | 6,044,367 ( 54.72 %) | 0 | 54.72 % |
Company contact information
Nutriband, Inc.
121 South Orange Avenue Suite 1500
32801, Orlando
+407 377 6695
http://www.nutriband.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |